1. Home
  2. SHG vs ONC Comparison

SHG vs ONC Comparison

Compare SHG & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shinhan Financial Group Co Ltd

SHG

Shinhan Financial Group Co Ltd

HOLD

Current Price

$67.39

Market Cap

28.9B

Sector

Finance

ML Signal

HOLD

ONC

BeiGene Ltd. American Depositary Shares

HOLD

Current Price

$309.50

Market Cap

31.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHG
ONC
Founded
1982
2010
Country
South Korea
Switzerland
Employees
N/A
12000
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.9B
31.4B
IPO Year
2003
N/A

Fundamental Metrics

Financial Performance
Metric
SHG
ONC
Price
$67.39
$309.50
Analyst Decision
Strong Buy
Analyst Count
0
12
Target Price
N/A
$374.75
AVG Volume (30 Days)
263.8K
187.3K
Earning Date
04-24-2026
05-06-2026
Dividend Yield
2.11%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.86
$747.23
Revenue Next Year
$3.66
$15.78
P/E Ratio
$9.79
$614.06
Revenue Growth
N/A
N/A
52 Week Low
$31.86
$227.40
52 Week High
$73.40
$385.22

Technical Indicators

Market Signals
Indicator
SHG
ONC
Relative Strength Index (RSI) 65.96 54.97
Support Level $58.10 $307.93
Resistance Level $73.40 $320.35
Average True Range (ATR) 1.41 7.68
MACD 0.76 4.77
Stochastic Oscillator 96.10 82.89

Price Performance

Historical Comparison
SHG
ONC

About SHG Shinhan Financial Group Co Ltd

Shinhan Financial Group Co Ltd is a Korean banking group. Along with its subsidiaries the company provides, comprehensive financial services which consist of commercial banking services, credit card services, securities services, insurance, credit services, and asset management services, including securities investment trust management, investment advisory, call transaction, domestic and foreign private equity fund business, and other services. The majority of the revenue is generated from its Banking business which includes retail, corporate, international, and other banking services the company offers.

About ONC BeiGene Ltd. American Depositary Shares

BeOne Medicines Ltd is a holding company. Through its subsidiaries, it operates as an oncology-focused biopharmaceutical company engaged in the discovery and development of treatments for cancer. Its portfolio includes BRUKINSA (a Bruton's tyrosine kinase (BTK) inhibitor), sonrotoclax (a B-cell lymphoma 2 (BCL2) inhibitor, and a BTK chimeric degradation activation compound (BTK-CDAC). The company develops and commercializes wholly owned therapeutic assets targeting multiple mechanisms of action in oncology. The company operates in one segment: pharmaceutical products. It generates the majority of its revenue from the sale of its biopharmaceutical products.

Share on Social Networks: